NEW YORK , Nov. 23, 2022 /PRNewswire/ -- The global medical aesthetics market is expected to grow at a CAGR of 13.71% during 2022-2027.
Read the full report: https://www.reportlinker.com/p06364038/?utm_source=PRN
The global medical aesthetics market trends include consumers seeking aesthetic procedures starting at a younger age, an uptick in men seeking cosmetic enhancement procedures, and an increasing preference for non-invasive cosmetic procedures instead of cosmetic surgery. The market is witnessing the launch of many advanced and innovative devices and products from global, regional, and local vendors. Facelifts, liposuction, botox & neuromodulators, skin resurfacing, and intense pulse light procedures are witnessing high demand from various age groups.
Medical aesthetics treatment focuses on treating and improving the appearance of the patient skin & body. Medical aesthetics treatments are not as aggressive as surgical interventions; they include minimally invasive and non-invasive surgical procedures that enhance the body shape, skin texture, and other benefits. It required high skills, knowledge, and training in human anatomy and physiology. The global medical aesthetics industry has changed in the past few years, with the overall demand for cosmetic treatments trending in a single direction; on another side despite the barriers and restrictions on cosmetic procedures significantly imposed by the COVID-19 pandemic, there was still a healthy rise of 3% from 2019. This reveals that the preference for improving appearance is strong, and there are enormous opportunities for the medical aesthetics market in the coming years.
New Medical Aesthetics Launched in the Medical Aesthetics Market
• In 2022, newly launched treatment such as Ellacor dermal micro-coring is becoming more popular for lines and laxity. • A newly developed treatment RHA Redensity is used for lip lines. RHA Redensity gets approval for the correction of moderate and severe lip lines. • In 2022, a new thread lift, “APTOS, " was launched. The Aptos PLLA/PCL treads are developed from a novel blend of polymer material. These threads have good tissue gripping strengths with longer-lasting results. • The new glow-boosting injectable “Volite†is more akin to that of a laser for enhancing skin quality, tone, and texture. • The newly developed Sculptra for cellulite is collagen stimulating injectables indication used off-label for many years for the augmentation of the buttocks wrap up with clinical trials expected in 2022. • The breast-enhancing implant A Cleavage will be available for patient use in 2022.
In the global medical aesthetics market, platelet-rich plasma is a highly popular cosmetic injectable medical treatment that helps nurture the skin appearance in aged people due to the ability to naturally rejuvenate the skin and repair and treat the aging sign by using the patient’s platelet-rich blood cells. This procedure has become more trending in recent years. In addition, the safety and rapid result ability deliver significant market growth opportunities for key players. Several factors play a vital role in the rising demand for PRP like in cosmetic procedures, PRP is applicable for hair loss and skin rejuvenation. In hair loss, PRP is commonly used for treating male pattern baldness for both purposes, such as hair loss prevention and promoting new hair growth. Dermatologists and plastic surgeons highly recommend the PRP procedure in high-income countries to improve skin appearance and overall health.
The advancement in medical aesthetics procedures will expect to achieve significant market growth. The medical aesthetics market is overgrowing with aesthetic dermatology sectors, including innovations in botanical blends in hair care, skincare, and others. The procedures, methodologies, and systems applied for dermatology procedures in the past were completely different from recent years. The significant changes in dermatology care and advancement in technology in skincare and medical aesthetics paved the direction for innumerable procedures that reduced the side effects. Laser applications are highly adopted for treating gentle vascular birthmarks, haemangioma, and other skin issues.
The Surge in Demand for Minimally Invasive & Non-invasive Aesthetic Procedures
• The demand for minimally invasive procedures increased significantly in recent years across all demographics. In addition, non-invasive treatments are a more accessible entry point in the medical aesthetic market for men and young people who are highly curious about their appearance and well-known about medical aesthetics. It indicated that the non-invasive procedures are a good fit for many consumers due to their affordable cost, low downtime, and lower risk. Increasing Per Capita Expenditure & Acceptance of Aesthetic Procedure
• Over the decade, the rising awareness about medical aesthetic solutions and increasing expenditure on personal care/cosmeceutical significantly induced medical aesthetics market growth. In 2022, the Aesthetic Society report revealed that the increasing expense for aesthetic solutions had given high market growth in recent years. People spent approximately USD 9.3 billion on aesthetic procedures in 2020. Of that, around USD 3 billion was registered for non-invasive treatment and USD 6 billion for invasive treatments. From 2019 to 2020, the expenditure for aesthetic procedures increased to almost 80%. In 2019, approximately USD 8.2 billion was spent on aesthetic procedures. This significant growth shows the rising expenditure and awareness about medical aesthetic procedures.
• The youth and aging population are the primary users of medical aesthetics treatment. These treatments to combat aging have emerged from anti-aging creams to approved cosmetic procedures. Currently, more and more young population are turning to cosmetic and aesthetic procedures to prevent their bodies from aging.
Medical Tourism Contributing to Surge in Medical Aesthetic Procedures
• Medical tourism is expanding globally, with patients seeking cosmetic surgery abroad. The changes caused by the globalization of medical services, the shift of lifestyle with displaying a healthy lifestyle, attention to the figure, and well-being associated with external appearance, combined with the willingness to travel, have given rise to a new segment of health tourism, that is aesthetic medicine tourism.
SEGMENTATION ANALYSIS INSIGHTS BY PROCEDURE
The medical aesthetics market by procedure type includes non-invasive and minimally invasive cosmetic procedures aimed at improving the physical appearance and satisfaction of the target patient. The minimally invasive procedure segment accounts for 57.14% highest market share, and non-invasive procedures account for 42.86% market share in 2021. Minimally invasive and non-invasive aesthetic procedures are trending and widely accepted globally, owing to fewer surgical interventions, low downtime, less pain, and high safety/efficacy.
Segmentation by Procedures • Minimally Invasive • Non-Invasive
The global medical aesthetics market by product type is dominated by the body contouring devices segment and accounts for a 27.38% market share. The market is by product type segments into body contouring devices, laser & energy-based devices, cosmetic implants, derma fillers & neuromodulators, micro-needling & chemical peels, microdermabrasion, and others (thread lift and skin lighteners). The increasing number of minimally invasive medical aesthetic procedures drive the segmental growth to reduce fat and body shaping and accelerate the higher segmental growth in 2021. Behind body countering devices, lased and energy-based devices accounted for a 21.86% market share and indicated rapid industry growth.
Segmentation by Product • Body Contouring Devices • Laser & Energy Based Devices • Cosmetic Implants • Derma Filler & Neuromodulators • Microneedling & Chemical Peels • Microdermabrasion • Other
Body contouring & cellulite reduction, skin tightening and resurfacing, facial aesthetics, breast augmentation, and others are the key segments by application in the global medical aesthetic market. In which body contouring & cellulite reduction application segment accounted for a 30.58% market share. The increasing demand for fat reduction, cellulite reduction, and liposuction procedures drives segmental growth. Skin tighteners and resurfacing are also becoming more popular in recent years, which is expected to achieve significant growth in the upcoming time.
Segmentation by Application • Body Contouring & Cellulite Reduction • Skin Tightening & Skin Lighteners • Facial Aesthetic • Breast Augmentation • Others
The global medical aesthetics market is segmented into hospitals & skin clinics, medical spas & beauty centers, and homecare on end-users basics. In 2021, hospitals and skin clinics accounted for a 55.24% market share, dominating the other segments. The increasing demand for minimally invasive and non-invasive procedures and rising awareness drive the high hospital visits and fuel segmental growth. Also, medical aesthetic treatments show easily accessible and deliverable advancements in hospitals and clinics, which drives segmental growth.
Segmentation by End-Users • Hospital & Skin Clinics • Medical Spa & Beauty Centres • Homecare
GEOGRAPHICAL ANALYSIS North America dominates the global medical aesthetics market and is expected to grow with a CAGR of 12.52% during the forecast period. The factors that propel the market growth in the region are the higher expenditure on medical aesthetic procedures, well-established healthcare infrastructure, and access to medical aesthetic procedures. In North America , the U.S. is a well-developed country that solely drives significant industry growth. In the U.S., liposuction, breast augmentation, and tummy tuck medical aesthetic procedures are in high demand. Among all regions, APAC is expected to grow faster, with a CAGR of around 15% during the forecast period. The rising aging population, the increasing acceptance and demand for cosmetic surgeries, and expenditure on medical aesthetic procedures show significant market growth opportunities in the region. In addition, the growing access to medical aesthetic procedures in Japan , China , India , South Korea , and Australia shows significant improvement.
Segmentation by Geography • North America o U.S. o Canada • Europe o Germany o France o UK o Italy o Spain • APAC o Japan o China o India o South Korea o Australia • Latin America o Brazil o Mexico o Argentina • Middle East & Africa o Turkey o Saudi Arabia o South Africa
The global medical aesthetics market is highly competitive and dynamic, with many international, regional, and local vendors offering a diverse range of medical aesthetic procedure products, treatments, and devices to the end-user. Global players such as AbbVie (Allergan), Sisram Medical, Cutera Inc., Lumenis Inc., Bausch & Lomb, and El En Spa are some of the primary industry players that consistently influence the competition in the industry. Based on geography, most industry players are headquartered in the U.S., Japan , European Region, and APAC region. One of the U.S.-based companies, AbbVie leading industry player in the medical aesthetics market with a broad spectrum of innovative and advanced solutions for solving serious health issues. In 2021, AbbVie acquired Allergan, the leading company in the medical aesthetics market. This acquisition creates a new product portfolio in AbbVie’s product portfolio. Also, the highly demanded and popular Botox comes under the AbbVie product category. Botox individually influences high competition in the industry.
Key Vendors • AbbVie (Allergan) • Bausch Health Companies • Candela • Cutera • Cynosure • EL.En. S.p.A. • Galderma • Johnson & Johnson • Lumenis • Merz Pharma • Sientra • Sinclair • Sisram Medical
Other Prominent Vendors • Aerolase • Aesthetics Biomedical • Asclepion Laser Technologies • Astanza Laser • Beijing Sanhe Beauty S & T Co. • Beijing ADSS Development • Biolitec • Biotec Italia • BISON Medical • Bluecore Company • Brera Medical Technologies S.R.L. • BTL Aesthetics • Cartessa Aesthetics • Dominion Aesthetic Technologies • Erchonia • ENDYMED • F Care Systems • Gigaalaser • GSD - Global Skin Dermatologist • InMode Aesthetic Solutions • Leaflife Technology • LINLINE Medical Systems • Lutronic • Lynton Lasers • MedArt ApS • Microaire Surgical Instruments • Medytox • Meyer-Haake • PhotoMedex • Revance Aesthetics • Sciton • ThermiGen • Venus Concept • Wavemed • Zimmer MedizinSysteme
KEY QUESTIONS ANSWERED 1. What is the size of the global medical aesthetics market? 2. What is the global medical aesthetics market growth? 3. What are the trends in the global medical aesthetics market? 4. Who are the key players in the global medical aesthetics market? 5. Which region will dominate the global medical aesthetics market share?
Read the full report: https://www.reportlinker.com/p06364038/?utm_source=PRN
About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________ Contact Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001
View original content:https://www.prnewswire.com/news-releases/the-global-medical-aesthetics-market-is-expected-to-grow-at-a-cagr-of-13-71-during-2022-2027--301684979.html
Gossamer Bio Inc (NASDAQ: GOSS) announced topline results for the TORREY Phase 2 study of seralutinib in patients with pulmonary arterial hypertension (PAH). A mean difference in pulmonary vascular resistance (PVR) between the placebo and seralutinib arms of -96.1 dynes, equating to a placebo-corrected improvement of 14.3%, was observed in the study. An observed mean difference in six-minute walk distance (6MWD) between placebo and seralutinib of 6.5 meters numerically favored the seralutinib ar
Investors and analysts were unimpressed by trial results on the company's combination therapy to treat non-small cell lung cancer.
Investing in small-cap stocks can be very risky. Let's consider two small-cap stocks that carry above-average risk but that could soar as early as next year if things work out: Bluebird Bio (NASDAQ: BLUE) and Krystal Biotech (NASDAQ: KRYS). Bluebird Bio is a biotech that seeks to develop gene-editing treatments for rare illnesses.
Mirati said almost half of patients responded to its lung cancer regimen, but MRTX stock crashed on questions about its market opportunity.
Only last week, the company was warned about its stock price; this week it's looking at putting a premium on the price of its second FDA-approved drug.
Her friend and co-star John Travolta called her one of the "most special relationships I’ve ever had."
Consider, for instance, Editas Medicine (NASDAQ: EDIT) and BioXcel Therapeutics (NASDAQ: BTAI). Let's consider why Editas Medicine and BioXcel Therapeutics are worth keeping an eye on right now, and whether the potential rewards of investing in these companies outweigh the risks. The company is down by 61% this year, a terrible performance it partly owes to market-wide troubles.
Biogen's (BIIB) tofersen, if approved, will be the first genetically-targeted treatment for SOD1-ALS in Europe.
Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM) (Nasdaq: PHAR) announces today that the positive results of a Phase 3 clinical trial of the investigational drug leniolisib, an oral, selective phosphoinositide 3-kinase delta (PI3Kδ) inhibitor, in adult and adolescent patients with activated phosphoinositide 3-kinase delta syndrome (APDS), a rare primary immunodeficiency, have been published in Blood,1 the peer-reviewed international medical journal of the American So
A for-profit California company saw windfall dividend — and patients scrambled for care, a CBS News investigation found.
Soligenix Positioned for Growth: Late-stage Pipeline and Key Q4 Milestones
Mirati Therapeutics Inc (NASDAQ: MRTX) announced preliminary results from the KRYSTAL-7 Phase 2 trial and KRYSTAL-1 Phase 1b cohort of adagrasib combined with Merck & Co Inc's (NYSE: MRK) Keytruda (pembrolizumab) in previously untreated metastatic lung cancer patients, harboring a KRASG12C mutation. Early data shows that a combination treatment demonstrated promising preliminary clinical activity across all PD-L1 subgroups with an objective response rate (ORR) of 49%, with a manageable safety pr
Atai, Biogen, and Sage are working to develop new treatments for mental illness.
More than half of the calories consumed by Americans come from this high-risk food group, which is associated with cognitive decline, cancer and heart disease
The data presented for Eisai and Biogen’s drug wasn’t convincing enough to settle a debate among experts, but investors are betting on commercial success anyway.
SimpleImages / GettyThe fight against COVID seems to have fallen into a ping-ponging rhythm at this point, where every step forward seems undercut by one backward. Vaccines are available, and hospitalization rates have fallen dramatically from previous peaks. But just a sliver of eligible Americans have received the most recent bivalent shot, and the specter of a new, somehow worse variant looms large in our collective psyche. Elsewhere, such as in China, we seem to be losing ground to the virus
(Bloomberg) -- China is set to announce a further relaxation of Covid control measures as soon as today — including allowing some infected people to home quarantine as a nationwide policy, and reining in unnecessary testing — according to people familiar with the matter, as the government continues to quickly ease its zero-tolerance strategy amid growing public discontent. Most Read from BloombergTrump Companies Are Convicted in NY Criminal Tax Fraud TrialWall Street Goes Risk Off as Bank CEOs S
Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and development announced today significant results from the study of Onternabez combined with Favipiravir against ARDS (acute respiratory distress syndrome), Sepsis, and COVID-19 through PREPAiRE, an AI (Artificial Intelligence) powered platform which purposely integrates target identification, validation, lead discovery optimization, drug synthesis, and preclin
The actress ended up losing some of her hair during chemotherapy, and now she's celebrating its regrowth
The toxicology report reveals past cocaine, marijuana use.